Theranexus, a unique clinical stage pharmaceutical company, has developed a versatile proprietary technology leading to first in class products to address severe unmet medical needs in brain disorders.
Location: France, Auvergne-Rhône-Alpes, Lyon
Member count: 11-50
Founded date: 2013
Investors 3
Mentions in press and media 11
| Date | Title | Description | Category | Author | Source |
| 03.02.2022 | THERANEXUS... | THERANEXUS AND BBDF START RECR... | - | - | marketscre... |
| 13.01.2022 | Theranexus... | Lyon, 13 January 2022 – Theran... | - | - | marketscre... |
| 20.12.2021 | Theranexus... | Lyon, December 20, 2021 – Ther... | - | - | marketscre... |
| 20.12.2021 | THERANEXUS... | THERANEXUS ANNOUNCES ITS FINAN... | - | - | marketscre... |
| 19.10.2021 | Theranexus... | Lyon, 19 October 2021 – Theran... | - | - | marketscre... |
| 19.10.2021 | Theranexus... | THERANEXUS PUBLISHES ITS CASH ... | - | - | marketscre... |
| 30.09.2021 | Theranexus... | THERANEXUS ANNOUNCES ITS FIRST... | - | - | marketscre... |
| 08.07.2021 | Theranexus... | THERANEXUS PUBLISHES ITS CASH ... | - | - | marketscre... |
| 07.04.2021 | THERANEXUS... | 2020 FULL-YEAR RESULTS AND UP... | - | - | marketscre... |
| - | Theranexus... | A major result for the company... | - | - | sofimacinn... |
Show more